Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hinchliffe

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Reproductive Biology|December 4, 2018
Neither male age nor semen parameters influence clinical pregnancy or live birth outcomes from IVFUma Mariappen, Kevin N Keane, Peter M Hinchliffe, et al.
BMJ Open|October 11, 2017
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosisKevin N Keane, John L Yovich, Anahita Hamidi, et al.
Drug Design, Development and Therapy|August 27, 2016
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndromeJohn L Yovich, Birgit Alsbjerg, Jason L Conceicao, et al.
Reproductive Biomedicine Online|November 14, 2017
Finding a place for corifollitropin within the PIVET FSH dosing algorithmsJohn L Yovich, Kevin N Keane, Gayatri Borude, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of miceN J McNally, T C Stephens, P R Twentyman, et al.
Drug Design, Development and Therapy|October 22, 2015
Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilizationKevin N Keane, Peter M Hinchliffe, Navid Namdar, et al.
Clinical and Experimental Reproductive Medicine|November 20, 2019
Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosisKevin N Keane, Yun Ye, Peter M Hinchliffe, et al.
Reproductive Biology|December 15, 2016
Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patientsKamarul B Mustafa, Kevin N Keane, Nikita L Walz, et al.
Reproductive Biology|May 27, 2018
An ICSI rate of 90% minimizes complete failed fertilization and provides satisfactory implantation rates without elevating fetal abnormalitiesJohn L Yovich, Jason L Conceicao, Nicole Marjanovich, et al.
Frontiers in Endocrinology|February 16, 2018
DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor PrognosisKevin N Keane, Peter M Hinchliffe, Philip K Rowlands, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Reproductive Biology|December 4, 2018
Neither male age nor semen parameters influence clinical pregnancy or live birth outcomes from IVFUma Mariappen, Kevin N Keane, Peter M Hinchliffe, et al.
BMJ Open|October 11, 2017
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosisKevin N Keane, John L Yovich, Anahita Hamidi, et al.
Drug Design, Development and Therapy|August 27, 2016
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndromeJohn L Yovich, Birgit Alsbjerg, Jason L Conceicao, et al.
Reproductive Biomedicine Online|November 14, 2017
Finding a place for corifollitropin within the PIVET FSH dosing algorithmsJohn L Yovich, Kevin N Keane, Gayatri Borude, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of miceN J McNally, T C Stephens, P R Twentyman, et al.
Drug Design, Development and Therapy|October 22, 2015
Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilizationKevin N Keane, Peter M Hinchliffe, Navid Namdar, et al.
Clinical and Experimental Reproductive Medicine|November 20, 2019
Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosisKevin N Keane, Yun Ye, Peter M Hinchliffe, et al.
Reproductive Biology|December 15, 2016
Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patientsKamarul B Mustafa, Kevin N Keane, Nikita L Walz, et al.
Reproductive Biology|May 27, 2018
An ICSI rate of 90% minimizes complete failed fertilization and provides satisfactory implantation rates without elevating fetal abnormalitiesJohn L Yovich, Jason L Conceicao, Nicole Marjanovich, et al.
Frontiers in Endocrinology|February 16, 2018
DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor PrognosisKevin N Keane, Peter M Hinchliffe, Philip K Rowlands, et al.
Pageof 4